Effect of replacement of fishmeal by soybean products with attractants supplementation on the growth performance, feed utilization, body composition, plasma physiological responses and hepatic antioxidant abilities of juvenile golden pompano Trachinotus ovatus

A feeding experiment was carried out to develop a practical diet with low fishmeal for juvenile golden pompano (Trachinotus ovatus) by substituting fishmeal protein with soybean products mixture. Six isocaloric (17.6 KJ g−1) diets were designed by replacing 0 (FM100), 5 (FM95), 10 (FM90), 15 (FM85), 20 (FM80), and 25% (FM75) of the fishmeal with soybean products mixture (SPM) (soybean meal and soybean protein concentrate). The experiment diets were supplemented with 1.5%, 3%, 4.5%, 6% and 7.5% squid paste as attractants or palatability enhancer. The experimental fish (6.9 g) were cultured in sea cages (1.0 m × 1.0 m × 1.5 m) with 25 fish in each cage. Fish were fed the corresponding experimental diets to satiation twice daily for 8 weeks. At the end of the feeding experiment, no differences were found in the final weight and weight gain (WG) of fish fed FM100, FM85, FM80, and FM75 diets (P > 0.05). The WG was significantly (P < 0.05) better in the fish-fed FM95 diet compared to FM100 and FM75 diets. FCR in diet FM95 and FM90 was significantly (P < 0.05) than that of FM80 and FM75, but these values were not significantly different from those in other treatments. Although the condition factor value in diets FM90, FM85, and FM80 was significantly (P < 0.05) higher than that of FM100, these values were not significantly different from the rest of the other groups. There was no statistical difference in SGR, FR, VSI, and survival rates among different dietary treatments. The plasma AST activity was significantly lower in fish fed FM90 diet compared to fish fed with control, FM85, FM80, and FM75 (P < 0.05). There was no significant difference in plasma AST among all dietary treatments except FM95 and FM90. In contrast, the plasma AKP activity showed the opposite trend. Compared with the control, the fish-fed FM80 and FM75 diets had significantly decreased plasma cholesterol, triglyceride total protein, albumin, and globulin level (P < 0.05) while significantly increasing plasma COR levels (P < 0.05). There was no significant difference in ALT, Urea and glucose values among all treatments. No statistical difference was observed among the FM100, FM80, and FM75 treatments for those of plasma LYZ activity, C3, and C4 levels. The hepatic T-AOC and SOD activities were significantly increased in fish fed the FM90 diet (P < 0.05) compared to those in fish fed with FM100 diet. According to the current experiment, it can be concluded that SPM supplemented with SP could partially substitute fishmeal (25%) for juvenile golden pompano without any adverse symptoms

Risk factors for in-hospital mortality after total arch procedure in patients with acute type A aortic dissection

ObjectKnowledge about the risk factors of in-hospital mortality for acute type A aortic dissection (ATAAD) patients who received total arch procedure is limited. This study aims to investigate preoperative and intraoperative risk factors of in-hospital mortality of these patients.MethodsFrom May 2014 to June 2018, 372 ATAAD patients received the total arch procedure in our institution. These patients were divided into survival and death groups, and patients` in-hospital data were retrospectively collected. Receiver operating characteristic curve analysis was adopted to determine the optimal cut-off value of continuous variables. Univariate and multivariable logistic regression analyses were used to detect independent risk factors for in-hospital mortality.ResultsA total of 321 patients were included in the survival group and 51 in the death group. Preoperative details showed that patients in the death group were older (55.4 ± 11.7 vs. 49.3 ± 12.6, P = 0.001), had more renal dysfunction (29.4% vs. 10.9%, P = 0.001) and coronary ostia dissection (29.4% vs. 12.2%, P = 0.001), and decreased left ventricular ejection fraction (LVEF) (57.5 ± 7.9% vs. 59.8 ± 7.3%, P = 0.032). Intraoperative results showed that more patients in the death group experienced concomitant coronary artery bypass grafting (35.3% vs. 15.3%, P = 0.001) with increased cardiopulmonary bypass (CPB) time (165.7 ± 39.0 vs. 149.4 ± 35.8 min, P = 0.003), cross-clamp time (98.4 ± 24.5 vs. 90.2 ± 26.9 min, P = 0.044), and red blood cell transfusion (913.7 ± 629.0 vs. 709.7 ± 686.6 ml, P = 0.047). Logistic regression analysis showed that age &gt;55 years, renal dysfunction, CPB time &gt;144 min, and RBC transfusion &gt;1,300 ml were independent risk factors for in-hospital mortality in patients with ATAAD.ConclusionIn the present study, we identified that older age, preoperative renal dysfunction, long CPB time, and intraoperative massive transfusion were risk factors for in-hospital mortality in ATAAD patients with the total arch procedure

Effect of Dietary Marine Red Yeast Rhodotorula mucilaginosa on the Growth Performance, and also Non-Specific Immune Responses of Juvenile Golden Pompano Trachinotus Ovatus when Challenged with Vibrio Harveyi

The present study was conducted to investigate the effects of dietary marine red yeast Rhodotorula mucilaginosa supplementation on the growth performance, non-specific immune responses, and resistance to the pathogen Vibrio harveyi in Golden Pompano Trachinotus ovatus. A basal diet was supplemented with R. mucilaginosa at 0‰ (control), 1‰, 2‰, 3‰, 4‰, and 5‰ for 8 weeks. After the 8-week feeding trial, weight gain (WG) and specific growth rate (SGR) were significantly affected by the R. mucilaginosa levels, with the highest WG and SGR occurring at the 1‰ R. mucilaginosa level (P<0.05). Compared to the control, the 4 and 5‰ R. mucilaginosa groups had significantly increased lysozyme (LYZ) and alkaline phosphatase (AKP) activity, but a decrease in nitric oxide synthase (NOS) was noted (P<0.05). Compared to the control, the 2, 3 and 4‰ R. mucilaginosa groups had significantly increased hepatic superoxide dismutase (SOD) activity (P<0.05), while hepatic malondialdehyde (MDA) content decreased significantly (P<0.05). After challenge with V. harveyi, the group supplemented with 1‰ R. mucilaginosa had 100% survival rate. In addition, compared to the control group prior to challenge, the serum C3 level significantly increased in the group supplemented with 2‰ R. Mucilaginosa (P < 0.05). Compared to the control 12 h and 48h after challenge, serum C4 levels in the 4‰ R. Mucilaginosa group increased significantly (P<0.05). Our results suggest that ingestion of a basal diet supplemented with 1-3‰ R. mucilaginosa in T. ovatus could enhance resistance against the pathogen Vibrio harveyi

Correlation of Aquaporin 3 Expression with the Clinicopathologic Characteristics of Non-small Cell Lung Cancer

Background and objective Lung cancer is a major health problem worldwide. The aim of this study is to investigate aquaporin 3 (AQP3) expression and its relationship with the clinicopathologic characteristics of non-small cell lung cancer (NSCLC). Methods AQP3 expression and the microvascular density (MVD) of tissue samples from 180 cases with NSCLC were detected by immunohistochemistry. Results AQP3 expression was negative in 25 (13.9%), positive in 67 (37.2%), and strongly positive in 88 (48.9%) of the 180 cases, which was significantly higher than that in the normal tissue (P&lt;0.01). A significant correlation was found between AQP3 expression and MVD (P&lt;0.01), whereas a high MVD was found among patients with strongly positive AQP3 expression. Male patients with positive or strongly positive AQP3 expression had significantly higher expression than female patients did (P=0.003). AQP3 expression was more significantly enhanced in adenocarcinoma than that in squamous cell carcinoma (P&lt;0.001). Statistical analysis indicated that the positive rate of AQP3 expression in well-differentiated carcinoma was significantly higher than that in poorly differentiated tumors (P&lt;0.001). Lymph node metastasis was positively correlated with high AQP3 expression (P=0.026). Conclusion AQP3 expression was closely correlated with MVD in NSCLC, whereas high MVD was frequently found in tumors with high AQP3 expression. AQP3, as a therapeutic target for inhibiting high AQP3 expression in NSCLC tissues, may weaken cancer cell proliferation, invasion, and metastasis